Bayesian designs to account for patient heterogeneity in phase II clinical trials

Peter F. Thall, J. Kyle Wathen

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Bayesian designs to account for patient heterogeneity in phase II clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences